FIGS (FIGS) Stock Forecast & Price Target

FIGS is supported by a clear acceleration in demand, with 2Q net sales up 28.8% to $197 million, active customers at a record 3.1 million, and revenue per active customer reaching an all-time high of $229, showing the brand is deepening engagement while broadening its customer base. Growth is also becoming more diversified across scrubwear, non-scrubwear, the U.S., international markets, TEAMS, and Community Hubs, while gross margin expanded to 75.2% and adjusted EBITDA rose to $36.6 million, underscoring improving operating leverage and strong execution. The company’s healthy balance sheet with no debt, strong free cash flow, and raised guidance for 2026 point to durable multi-year growth potential, especially as international and other expansion vectors continue to gain momentum.

FIGS is facing a vulnerable setup because its valuation depends on strong execution and a premium multiple that may be difficult to sustain if growth or profitability disappoints. The company remains exposed to macro headwinds, including a weakening economy, rising inflation, tariffs, and supply chain or logistics disruptions, any of which could pressure demand and margins even in a relatively recession-resistant healthcare apparel category. Its lifestyle products are still early in development, and expanding beyond core scrubs could intensify competition from established activewear brands while also exposing the business to slower-than-expected adoption.